138 related articles for article (PubMed ID: 25204998)
1. Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.
Filhon B; Dumesnil C; Van Dreden P; Schneider P; Vasse M; Vannier JP
Thromb Res; 2014 Nov; 134(5):1164-6. PubMed ID: 25204998
[No Abstract] [Full Text] [Related]
2. The challenge of obesity in paediatric leukaemia treatment: it is not just size that matters.
Tolbert J; Kearns GL
Arch Dis Child; 2015 Jan; 100(1):101-5. PubMed ID: 25336436
[TBL] [Abstract][Full Text] [Related]
3. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
4. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
5. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma.
Halalsheh H; Bazzeh F; Alkayed K; Salami K; Madanat F
J Pediatr Hematol Oncol; 2013 Aug; 35(6):470-2. PubMed ID: 23138114
[TBL] [Abstract][Full Text] [Related]
6. Thioguanine versus mercaptopurine in childhood ALL.
Stanulla M; Schünemann HJ
Lancet; 2006 Oct; 368(9544):1304-6. PubMed ID: 17046444
[No Abstract] [Full Text] [Related]
7. The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
Adam de Beaumais T; Dervieux T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
Cancer Chemother Pharmacol; 2010 Sep; 66(4):653-8. PubMed ID: 20033410
[TBL] [Abstract][Full Text] [Related]
8. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
[TBL] [Abstract][Full Text] [Related]
9. [Better therapeutic potential for azathioprine and mercaptopurine].
Bergan S; Norge O
Lakartidningen; 2000 Apr; 97(16):1999-2000. PubMed ID: 10826362
[No Abstract] [Full Text] [Related]
10. Mercaptopurine-induced fever: hypersensitivity reaction in a patient with acute lymphoblastic leukemia.
Chen LJ; Nightingale G; Baer MR
Pharmacotherapy; 2010 Jan; 30(1):113. PubMed ID: 20030482
[TBL] [Abstract][Full Text] [Related]
11. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Karas-Kuzelicki N; Mlinaric-Rascan I
Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
[TBL] [Abstract][Full Text] [Related]
12. Decreased activity of clotting factor V during ALL consolidation treatment with mercaptopurine in a child.
Vignand C; Couillault G; Jolimoy G; Dutrillaux F; Sgro C
Ann Pharmacother; 2006 Oct; 40(10):1887-8. PubMed ID: 16954327
[No Abstract] [Full Text] [Related]
13. Severe hypoglycemic seizures in a child receiving 6-mercaptopurine.
El-Bitar MK; Muwakkit SA; Dabbagh O
J Pediatr Hematol Oncol; 2011 Mar; 33(2):e75-6. PubMed ID: 21343747
[TBL] [Abstract][Full Text] [Related]
14. Nuclear winter.
Lesesve JF; Mansuy L
Transfusion; 2005 Sep; 45(9):1403. PubMed ID: 16131370
[No Abstract] [Full Text] [Related]
15. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
[TBL] [Abstract][Full Text] [Related]
16. A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trial.
Hanff LM; Mathot RA; Smeets O; Postma DJ; Ramnarain S; Vermes A; Pieters R; Zwaan CM
Int J Clin Pharmacol Ther; 2014 Aug; 52(8):653-62. PubMed ID: 24800919
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.
Erb N; Harms DO; Janka-Schaub G
Cancer Chemother Pharmacol; 1998; 42(4):266-72. PubMed ID: 9744770
[TBL] [Abstract][Full Text] [Related]
20. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]